Understanding the pathophysiology of diseases through the relationships between pathway sub-components, and how this can be leveraged to treat individual conditions
Analyzing the advantages and disadvantages of targeting on different levels
Discussing trends in the complement therapeutics space between points of inhibition and disease areas
16.10 Afternoon Refreshments & Networking
17.00 Complement-based Drug Development Round Tables
Exploring the Micro-Landscape of Complement Related Compounds
-Which cells are responsible for the production of key compounds?
-At what rate are components cleared from cells and replenished?
-What implications do these areas have for the efficacy of complement-based drugs?
The Future of Complement Therapeutics
-What are the most interesting cutting edge developments in this area that could have great potential?
-How can companies begin preparation to capitalize on emerging market trends in coming years?
Expanding Complement Therapeutics into Common Diseases Areas
-What alterations must be made to clinical trial design in order to move beyond rare and orphan diseases?
-What implications will moving into common disease areas have for complement therapeutics – how can we begin to prepare for perceived challenges?
Meeting Dosing and Efficacy Regulatory Requirements
-What experiences have individuals had regarding PKPD and safety guidelines in the complement therapeutics space?
-How can we ensure that drugs meet the required levels of therapeutic efficacy for market approval?
-What are the biggest obstacles to getting complement-based drugs through the revelatory approval process?
Preparing for Commercialization of Complement Therapies
-How can drug production processes be upscaled to meet both initial market demand and subsequent growth?
-How can logistical issues with manufacture, storage and transport of treatments be overcome?
-What future methods for treatment delivery may solve the current patient access problem?
Hyatt Regency Boston
One Avenue de Lafayette
Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.